Health In Tech (HIT) Income Statement (2024 - 2026)
Income Statement report data from Mar 31, 2024 to Mar 31, 2026 for Health In Tech (HIT).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||
Total Revenue | 8.82M (-3.29%) | 9.12M (-8.16%) | 9.93M (+3.65%) | 9.58M (+7.28%) | 8.93M (+76.83%) | 5.05M (+13.23%) | 4.46M (-8.23%) | 4.86M (-6.72%) | 5.21M |
Cost Of Revenue | 4.26M (+26.04%) | 3.38M (+0.90%) | 3.35M (+11.67%) | 3.00M (+12.78%) | 2.66M (+139.64%) | 1.11M (+13.27%) | 980K (+1.03%) | 970K (-2.02%) | 990K |
Costof Goods And Services Sold | 4.26M (+26.04%) | 3.38M (+0.90%) | 3.35M (+11.67%) | 3.00M (+12.78%) | 2.66M (+139.64%) | 1.11M (+13.27%) | 980K (+1.03%) | 970K (-2.02%) | 990K |
Gross Profit | 4.51M (+9.20%) | 4.13M (-19.65%) | 5.14M (-18.54%) | 6.31M (+17.72%) | 5.36M (+41.05%) | 3.80M (+9.20%) | 3.48M (-13.65%) | 4.03M (-2.66%) | 4.14M |
Operating Expenses | |||||||||
Research And Development | 920K (+338.10%) | 210K (-12.50%) | 240K (-58.62%) | 580K (+7.41%) | 540K (-14.29%) | 630K (-12.50%) | 720K (+2.86%) | 700K (-7.89%) | 760K |
Selling General And Administrative | 3.46M (+8.81%) | 3.18M (-7.83%) | 3.45M (-8.73%) | 3.78M (+16.31%) | 3.25M (+14.04%) | 2.85M (+57.46%) | 1.81M (-0.55%) | 1.82M (-9.00%) | 2.00M |
Operating Expenses | 6.67M (+55.12%) | 4.30M (-7.53%) | 4.65M (-16.67%) | 5.58M (+14.58%) | 4.87M (+18.49%) | 4.11M (+35.20%) | 3.04M (-12.89%) | 3.49M (-8.16%) | 3.80M |
Depreciation And Amortization | 400K (-2.44%) | 410K (+86.36%) | 220K (+57.14%) | 140K (0.00%) | 140K (0.00%) | 140K (0.00%) | 140K (+7.69%) | 130K (0.00%) | 130K |
Operating Income | |||||||||
Operating Income | 3.59M (-8.42%) | 3.92M (-20.16%) | 4.91M (-14.31%) | 5.73M (+18.88%) | 4.82M (+52.53%) | 3.16M (+14.49%) | 2.76M (-17.12%) | 3.33M (-1.19%) | 3.37M |
Ebit | -2.07M (+370.45%) | -440.00K | 600K (-27.71%) | 830K (+22.06%) | 680K | -110.00K | 410K (+2.50%) | 400K (+110.53%) | 190K |
EBITDA | -1.66M (+5433.33%) | -30.00K | 820K (-15.46%) | 970K (+18.29%) | 820K (+2633.33%) | 30K (-95.77%) | 710K (+1.43%) | 700K (+42.86%) | 490K |
Other Income / Expenses | |||||||||
Interest Income | 70K (-30.00%) | 100K (-9.09%) | 110K (0.00%) | 110K (+22.22%) | 90K (+200.00%) | 30K (-25.00%) | 40K (+33.33%) | 30K (+50.00%) | 20K |
Interest Expense | - | - | - | - | - | - | 170K (0.00%) | 170K (0.00%) | 170K |
Net Interest Income | 70K (-30.00%) | 100K (-9.09%) | 110K (0.00%) | 110K (+22.22%) | 90K (+200.00%) | 30K (-25.00%) | 40K (+33.33%) | 30K (+50.00%) | 20K |
Other Non Operating Income | 90K (-40.00%) | 150K (+36.36%) | 110K (0.00%) | 110K (-45.00%) | 200K | -100.00K (+233.33%) | -30.00K (-76.92%) | -130.00K (-7.14%) | -140.00K |
Net Income | |||||||||
Income Before Tax | -2.07M (+370.45%) | -440.00K | 600K (-27.71%) | 830K (+22.06%) | 680K | -110.00K | 410K (+2.50%) | 400K (+110.53%) | 190K |
Income Tax Expense | -480.00K (+242.86%) | -140.00K | 150K (-25.00%) | 200K (+5.26%) | 190K (+533.33%) | 30K (0.00%) | 30K (-50.00%) | 60K (-33.33%) | 90K |
Net Income From Continuing Operations | -1.59M (+430.00%) | -300.00K | 450K (-28.57%) | 630K (+26.00%) | 500K | -140.00K | 380K (+11.76%) | 340K (+240.00%) | 100K |
Net Income | -1.59M (+430.00%) | -300.00K | 450K (-28.57%) | 630K (+26.00%) | 500K | -140.00K | 380K (+11.76%) | 340K (+240.00%) | 100K |